stoxline Quote Chart Rank Option Currency Glossary
Zomedica Corp. (ZOM)
0.155  0.012 (8.39%)    03-01 16:00
Open: 0.1441
High: 0.1599
Volume: 11,971,232
Pre. Close: 0.143
Low: 0.1415
Market Cap: 152(M)
Technical analysis
2024-03-01 4:56:21 PM
Short term     
Mid term     
Targets 6-month :  0.18 1-year :  0.21
Resists First :  0.15 Second :  0.18
Pivot price 0.13
Supports First :  0.13 Second :  0.11
MAs MA(5) :  0.13 MA(20) :  0.13
MA(100) :  0.16 MA(250) :  0.18
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  78.8 D(3) :  54.5
RSI RSI(14): 62.1
52-week High :  0.27 Low :  0.11
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ZOM ] has closed Bollinger Bands are 10.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.16 - 0.16 0.16 - 0.16
Low: 0.14 - 0.14 0.14 - 0.14
Close: 0.15 - 0.15 0.15 - 0.16
Company Description

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Headline News

Thu, 29 Feb 2024
Zomedica (NYSEAMERICAN:ZOM) Trading Up 10% - American Banking and Market News - AmericanBankingNEWS

Tue, 13 Feb 2024
Transcript : Zomedica Corp. - Analyst/Investor Day -February 13, 2024 at 03:00 pm EST -

Sun, 11 Feb 2024
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update ... - Barron's

Thu, 08 Feb 2024
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences - Yahoo Finance

Tue, 06 Feb 2024
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET - Yahoo Finance

Tue, 06 Feb 2024
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share ... - Barron's

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Drug Manufacturers—Specialty & Generic
Shares Out 980 (M)
Shares Float 964 (M)
Held by Insiders 1.5 (%)
Held by Institutions 8.5 (%)
Shares Short 63,430 (K)
Shares Short P.Month 62,890 (K)
Stock Financials
EPS -0.02
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.27
Profit Margin -62.3 %
Operating Margin -93.8 %
Return on Assets (ttm) -5.7 %
Return on Equity (ttm) -5.7 %
Qtrly Rev. Growth 32.9 %
Gross Profit (p.s.) 0.01
Sales Per Share 0.02
EBITDA (p.s.) -0.03
Qtrly Earnings Growth 0 %
Operating Cash Flow -13 (M)
Levered Free Cash Flow -20 (M)
Stock Valuations
PE Ratio -7.75
PEG Ratio 0
Price to Book value 0.57
Price to Sales 6.32
Price to Cash Flow -11.39
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android